Disease Information & Support

www.lls.org/diseaseinformation

The Word:

donate

Facts and Statistics

Leukemia, lymphoma, myeloma and myelodysplastic syndromes (MDS) are types of cancer that can affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system. These cancers are all related since each are likely a result from acquired changes to the DNA of a single stem cell.

These facts and statistics are the most recent data (2013) from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program, Cancer Statistics Review (CSR) 1975-2010. The CSR reports cancer incidence, prevalence, survival and death statistics. For a more detailed explanation of the SEER data, download or order The Leukemia & Lymphoma Society's (LLS's) free publication Facts 2013.

New Cases

  • One person in the United States is diagnosed with a blood cancer approximately every four minutes.
  • An estimated combined total of 149,990 people in the United States will be diagnosed with leukemia, lymphoma or myeloma* in 2013.
  • New cases of leukemia, lymphoma and myeloma will account for 9 percent of the 1,660,290 new cancer cases diagnosed in the United States this year.

*MDS were included in the SEER statistics as separate entities beginning in 2007. Limited data are available.

Incidence

Incidence is the number of newly diagnosed cases for a specific cancer or for all cancers combined during a specific time period:

Incidence rates are usually presented as a specific number per 100,000 population. Overall incidence rates reported in 2013, per 100,000 population, are:

  • leukemia, 12.8 cases
  • non-Hodgkin lymphoma, 19.7 cases
  • Hodgkin lymphoma, 2.8 cases
  • myeloma, 5.9 cases
  • MDS, 4.8 cases

Prevalence

Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,129,813 people in the United States are living with, or are in remission from, leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma or myeloma.

Survival

Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.

5yr Survival Chart

Source: Facts 2013

Deaths

In general, the likelihood of dying from most types of leukemia, lymphoma or myeloma decreased from 2000 to 2010 (the most recent data available):

  • Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 54,630 people in the United States this year (2013).
  • These diseases are expected to account for nearly 9.4 percent of the deaths from cancer in 2013, based on the total of 580,350 cancer deaths.

More to Explore

last updated on Monday, August 19, 2013
btn_sharethis

Get Information
& Support

Contact an Information Specialist.